Survival of anti-mitochondrial antibody-positive and -negative primary biliary cirrhosis patients on ursodeoxycholic acid treatment

Digestive Diseases and Sciences
Meri KoulentakiElias A Kouroumalis

Abstract

The survival of 85 anti-mitochondrial antibody (AMA)-positive (mean Mayo risk score, 5.11) and 19 AMA-negative (mean Mayo risk score, 4.77) primary biliary cirrhosis patients, under ursodeoxycholic acid not subjected to liver transplantation, was compared with the estimated survival of a simulated control group of untreated patients created with the updated Mayo model and a control group from the general population. In the first 7 years 3 AMA-negative patients died, versus 12 under the Mayo model (P = 0.01), and 10 AMA-positive patients, versus 26 under the Mayo model (P < 0.005), with 7 expected deaths from the general population (P < 0.0001). At 10 years the cumulative survival differed in the treated patients overall (P < 0.0001) but not in the early primary biliary cirrhosis (stages I-II) patients compared to the general population. Therefore the survival of our patients treated with ursodeoxycholic acid is higher than that predicted from the Mayo model. Early treatment may prolong survival.

Citations

Jan 25, 2008·Orphanet Journal of Rare Diseases·Teru Kumagi, E Jenny Heathcote
Jul 16, 2009·Seminars in Immunopathology·Simon HohenesterUlrich Beuers
Nov 13, 2012·Clinics and Research in Hepatology and Gastroenterology·Christophe Corpechot
Aug 30, 2005·Annals of the New York Academy of Sciences·Sabine OerteltM Eric Gershwin
Aug 30, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christophe CorpechotRaoul Poupon
Oct 13, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Robert P MyersHude Quan
Jun 28, 2011·Journal of Hepatology·Christophe CorpechotRaoul Poupon
Jun 1, 2007·Autoimmunity Reviews·Elio TonuttiNicola Bizzaro
Jul 30, 2014·World Journal of Hepatology·Dimitrios N SamonakisElias A Kouroumalis
Aug 12, 2015·World Journal of Gastrointestinal Pharmacology and Therapeutics·Elias Kouroumalis, George Notas
Jul 20, 2006·The American Journal of Gastroenterology·Pieter C J ter BorgUNKNOWN Dutch PBC Study Group
Sep 27, 2007·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Christophe Corpechot, Raoul Poupon
Jun 29, 2021·Digestive Diseases and Sciences·Guilherme Grossi Lopes CançadoUNKNOWN Members of the Brazilian Cholestasis Study Group Consortium

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Hepatology : Official Journal of the American Association for the Study of Liver Diseases
Raoul PouponR Poupon
The Cochrane Database of Systematic Reviews
C Gluud, E Christensen
Hepatology : Official Journal of the American Association for the Study of Liver Diseases
C CorpechotR Poupon
© 2021 Meta ULC. All rights reserved